PROCEPT BioRobotics Corporation Common Stock (PRCT) is a publicly traded Healthcare sector company. As of May 21, 2026, PRCT trades at $27.87 with a market cap of $1.48B and a P/E ratio of -16.03. PRCT moved +8.57% today. Year to date, PRCT is -15.13%; over the trailing twelve months it is -52.50%. Its 52-week range spans $19.35 to $103.81. Analyst consensus is buy with an average price target of $36.50. Rallies surfaces PRCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PROCEPT BioRobotics Corporation Common Stock (PRCT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PRCT moved +8.57% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $27.87 |
| Market Cap | $1.48B |
| P/E Ratio | -16.03 |
| EPS | $-1.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $103.81 |
| 52-Week Low | $19.35 |
| Volume | 1.24M |
| Avg Volume | 0 |
| Revenue (TTM) | $308.05M |
| Net Income | $-95.57M |
| Gross Margin | 63.70% |
11 analysts cover PRCT: 0 strong buy, 7 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $36.50.